Bluerock Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Bluerock Therapeutics

Access the complete profile.

Bluerock Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	238 Main Street 3rd Floor Cambridge, MA 02142

Note: Revenues for privately held companies are statistical evaluations.


Bluerock Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Bluerock Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Bluerock Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Bluerock Therapeutics Annual Revenue and Growth Rate

Bluerock Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Bluerock Therapeutics's revenues are gauged from an analysis of company filings.

Bluerock Therapeutics's Income Statement (based on Industry Averages)

Bluerock Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Bluerock Therapeutics is developing and marketing. Bluerock Therapeutics doesn't have any recent trademark applications, indicating Bluerock Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
BLUEROCK THERAPEUTICS Cells for medical or clinical use; genetic material being cells and biological tissue cultures for medical or clinical use; cell therapy and genetic medicine-based pharmaceutical and therapeutic pharmaceutical preparations for the treatment of Parkinson's disease, cancer, cardiovascular disease, ophthalmological diseases, autoimmune disorders, neurological disorders, lysosomal disorders, central nervous system diseases, gastrointestinal disorders, dermatological disorders, inflammatory diseases, metabolic disorders, respiratory diseases, and endocrine diseases; pharmaceutical and therapeutic pharmaceutical preparations in the nature of cells for human use for treating Parkinson's disease, cancer, cardiovascular disease, ophthalmological diseases, autoimmune disorders, neurological disorders, lysosomal disorders, central nervous system diseases, gastrointestinal disorders, dermatological disorders, inflammatory diseases, metabolic disorders, respiratory diseases, and endocrine diseases through cell therapy or gene therapy; cell therapy and genetic medicine-based pharmaceutical preparations for the treatment of Parkinson's disease, cancer, cardiovascular disease, ophthalmological diseases, autoimmune disorders, neurological disorders, lysosomal disorders, central nervous system diseases, gastrointestinal disorders, dermatological disorders, inflammatory diseases, metabolic disorders, respiratory diseases, and endocrine diseases through gene therapy and cell therapy.	07/25/2022
BLUEROCK Providing medical information; providing a web site featuring medical information	03/07/2017

See all trademarks and details in the Full Report.

Market Share of Bluerock Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Bluerock Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Bluerock Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Other Companies at 238 Main Street, Cambridge MA

Company	Headquarters	Revenue ($ MM)
BEAM THERAPEUTICS	Cambridge, MA	100
CONSENSUS BUILDING INSTITUTE	Cambridge, MA	5
KERNAL BIOLOGICS	Cambridge, MA	4
NEXTPOINT THERAPEUTICS	Cambridge, MA	2
KENDALL DRUG	Cambridge, MA	0

Future Competition: Bluerock Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Bluerock Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)